We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




T-rays: New Imaging Technology

By Biotechdaily staff writers
Posted on 14 Sep 2005
An adaptable technology that can detect cracks in space shuttle foam, in addition to also offering the potential to see biological agents through a sealed envelope and detect tumors without harmful radiation, was recently discussed at a symposium at the annual meeting of the American Chemical Society, held in Washington, DC, USA in August 2005. More...


The session was co-chaired by T-ray specialists Dr. Xi-Cheng Zhang, a physicist and engineer at Rensselaer Polytechnic Institute (Troy, NY, USA), and Dr. Charles Schmuttenmaer, a chemist at Yale University (New Haven, CT, USA). T-rays are the next-generation development in imaging and sensing technology. Based on the terahertz (THz) region of the electromagnetic spectrum, defined by frequencies from 0.1-10 THz (just between infrared light and microwave radiation), T-rays may have potential for a wide variety of applications.

Objects at room temperature emit thermal energy in the THz range. This radiation is very useful for sensing and imaging objects, with significant advantages over other methods, according to Dr. Zhang. T-ray systems provide more than just images: they can offer valuable spectroscopic information about the composition of a compound, particularly in chemical and biological species--something that x-rays may not be able to do. T-rays are also safer than x-rays for biologic applications, according to Dr. Zhang, with photon energies that are one million times weaker than x-ray photons.

Until recently, scientists have had great difficulty controlling the potential of the THz region, mainly because of a scarcity of appropriate radiation sources. Dr. Zhang reported that new developments achieved at Rensselaer has allowed for the sensing of extremely small objects on the nanometer scale, as well as at large distances of more than 100 meters--an essential improvement for national security applications such as remote sensing of explosives. He has also collaborated with U.S. National Aeronautics Space Administration (NASA) with this technology, where THz imaging successfully detected defects in space shuttle foam.

T-ray applications could enable the label-free characterization of genetic material, identify a C-4 explosive hidden in the mail, and help scientists understand the complicated dynamics involved in protein folding, according to the researchers.






Related Links:
Rensselaer Polytechnic Institute

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.